Esomeprazole Magnesium Granule, Delayed Release
Product Images NDC 68382-848

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Esomeprazole Magnesium (NDC 68382-848). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Esomeprazole Magnesium For Delayed-release Oral Suspension (2b944206 1301 4554 Ba9a Cf18f294f507 01)

Chemical structure of Esomeprazole Magnesium with two water molecules (2H2O), showing the molecular arrangement including magnesium coordination and methoxy groups.*

FDA Label Image

Esomeprazole Magnesium For Delayed-release Oral Suspension (2b944206 1301 4554 Ba9a Cf18f294f507 02)

A line graph showing percent maintained over a 6-month period comparing Esomeprazole Magnesium granules delayed release at doses of 40 mg, 20 mg, and 10 mg, plus a placebo group. The x-axis represents months (0 to 6), and the y-axis shows percent maintained (0 to 100). Higher doses of Esomeprazole Magnesium maintain a greater percentage over time compared to placebo.*

FDA Label Image

Esomeprazole Magnesium For Delayed-release Oral Suspension (2b944206 1301 4554 Ba9a Cf18f294f507 03)

This is a line graph showing the percentage maintained over a 6-month period for Esomeprazole Magnesium at doses of 40 mg, 20 mg, and 10 mg compared to a placebo. The graph tracks four groups and displays changes in treatment maintenance percentage across time in months.*

FDA Label Image

Image (2b944206 1301 4554 Ba9a Cf18f294f507 04)

Line graph showing the percentage of patients symptom-free over 28 diary days for Esomeprazole Magnesium 40 mg, 20 mg, and placebo. The vertical axis represents the percent of patients symptom-free, from 0 to 100%, and the horizontal axis indicates diary days from 0 to 28. Three lines represent the treatment groups showing symptom relief progress over time.*

FDA Label Image

Image (2b944206 1301 4554 Ba9a Cf18f294f507 05)

A line graph showing the percent of patients symptom-free over a 28-day diary period. It compares three groups: Esomeprazole Magnesium 40 mg, Esomeprazole Magnesium 20 mg, and placebo, with the 40 mg group generally showing the highest symptom-free percentages, followed by the 20 mg group and then placebo.*

FDA Label Image

Esomeprazole Magnesium For Delayed-release Oral Suspension (2b944206 1301 4554 Ba9a Cf18f294f507 06)

Esomeprazole Magnesium for Delayed-Release Oral Suspension 20 mg packet label. The label includes the NDC number 68382-848-93, pharmacist dispensing instructions, and notes that the packet contains 20 mg of esomeprazole equivalent to 21.8 mg of esomeprazole magnesium dihydrate. The labeler is Zydus Pharmaceuticals USA Inc. The packaging is pink with black and gray text.*

FDA Label Image

Esomeprazole Magnesium For Delayed-release Oral Suspension (2b944206 1301 4554 Ba9a Cf18f294f507 07)

Packaging label for Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg strength. The label includes usage instructions, storage directions, and manufacturer information. It states the product is supplied by Zydus Pharmaceuticals USA Inc. and contains 30 single dose packets per container. The label is designed with regulatory details and a barcode visible.*

FDA Label Image

Esomeprazole Magnesium For Delayed-release Oral Suspension (2b944206 1301 4554 Ba9a Cf18f294f507 08)

Label for Esomeprazole Magnesium for Delayed-Release Oral Suspension 40 mg by Zydus Pharmaceuticals USA Inc. The label includes dosing instructions and pharmacist dispensing guidance. The packaging shows the NDC 68382-849-93 and highlights that the packet contains 40 mg esomeprazole delayed-release oral suspension. The label is designed for prescription usage only.*

FDA Label Image

Esomeprazole Magnesium For Delayed-release Oral Suspension (2b944206 1301 4554 Ba9a Cf18f294f507 09)

Packaging label for Esomeprazole Magnesium Delayed-Release Oral Suspension, 40 mg strength, in 30 single dose packets. The label includes dosing instructions, storage information, and manufacturer details for Zydus Pharmaceuticals USA Inc. The product is Rx only and contains delayed-release granules for oral suspension.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.